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Available online 30 November 2015Progenitor cells in the adult pancreas are potential sources of endocrine beta cells for treating type 1 diabetes.
Previously, we identiﬁed tri-potent progenitor cells in the adult (2–4 month-old) murine pancreas that were ca-
pable of self-renewal and differentiation into duct, acinar, and endocrine cells in vitro. These progenitor cells were
named pancreatic colony-forming units (PCFUs). However, because PCFUs are a minor population in the pancre-
as (~1%) they are difﬁcult to study. To enrich PCFUs, strategies using cell-surface marker analyses and
ﬂuorescence-activated cell sorting were developed. We found that CD133highCD71low cells, but not other cell
populations, enriched PCFUs by up to 30 fold compared to the unsorted cells. CD133highCD71low cells generated
primary, secondary, and subsequent colonies when serially re-plated inMatrigel-containing cultures, suggesting
self-renewal abilities. In the presence of a laminin hydrogel, CD133highCD71low cells gave rise to colonies that
contained duct, acinar, and Insulin+Glucagon+ double-hormonal endocrine cells. Colonies from the laminin hy-
drogel culture were implanted into diabetic mice, and ﬁveweeks later duct, acinar, and Insulin+Glucagon− cells
were detected in the grafts, demonstrating tri-lineage differentiation potential of CD133highCD71low cells. These
CD133highCD71low cells will enable future studies of putative adult pancreas stem cells in vivo.
© 2015 Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
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The pancreas plays a critical role in regulating metabolism and is
composed of threemajor cell lineages: acinar cells, which secrete diges-
tive enzymes such as amylase; duct cells, which transport digestive en-
zymes into the gut and secrete mucin to fend off pathogens; and
endocrine cells, which secrete hormones such as insulin and glucagon
that are important for glucose homeostasis.
Pancreas development follows a sequence of events regulated by
transcription factors. Around embryonic day (E) 8.5, murine pancreatic
endoderm expresses critical transcription factors, such as pancreas duo-
denal homeobox (Pdx) 1 and Sox9. Between E8.5 and E12.5, Pdx1+ and
Sox9+ ductal cells are multi-potential and capable of giving rise to all
three lineages in the adult pancreas (Gu et al., 2002; Zhou et al., 2007;
Kopp et al., 2011). After E12.5, the lineage potential of the ductal epithe-
lium becomes restricted (Gu et al., 2002; Zhou et al., 2007; Kopp et al.,
2011), and the up-regulation of another key transcription factor,C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
41L. Jin et al. / Stem Cell Research 16 (2016) 40–53neurogenin (Ngn) 3 is necessary for subsequent differentiation into en-
docrine cells (Apelqvist et al., 1999; Gradwohl et al., 2000).
There has been an intense debate about whether the adult pancreas
harbors stem and progenitor cells that can give rise to new insulin-
producing beta cells. Because of their roles as progenitors in the earlyFig. 1.CD133 and CD71are expressed in the adultmurine pancreas. (A) Flow cytometry analyses
fractionates CD133-expressing ductal cells, suggesting heterogeneity of ductal cells. (B) Region
(C)Double immunohistochemical stainingon frozen sections showed that CD133and CD71 exp
murine pancreas. (D) Immunohistochemical staining on adjacent slides prepared from formalin
bit antibodies. Results showed that Sox9+ ductal regions were also positive for CD71 staining. (
the CD133+ ductal cells with various intensities. The yellow arrow indicates a CD133+ duct cell
from RNA-seq analyses which are signiﬁcantly up-regulated in R2 versus R1 cells.embryo, duct cells in the adult pancreas have long been the assumed
source of new beta cells (Bonner-Weir et al., 2004). However, in
mouse models using Cre-Lox lineage-tracing techniques, contradictory
results either positively (Inada et al., 2008; Xu et al., 2008) or negatively
(Kopp et al., 2011; Dor et al., 2004; Furuyama et al., 2011; Kopinke &of dissociated pancreatic cells stainedwith antibodies against CD133 and CD71. CD71 sub-
s (R) 1 to 4 indicated in (A) were analyzed for gene expression by conventional qRT-PCR.
ressionswere locatedmostly in theductal structures (outlined by a dotted line) in the adult
-ﬁxed, parafﬁn-embedded pancreas. Both primary antibodies for Sox9 and CD71were rab-
E) Double immunostaining on frozen sections showed that Pdx1 protein was expressed in
expressing a higher level of Pdx1 than other duct cells. (F) Representative genes identiﬁed
Fig. 1 (continued).
42 L. Jin et al. / Stem Cell Research 16 (2016) 40–53Murtaugh, 2010; Teta et al., 2007; Solar et al., 2009) implicate ducts as
the source of progenitor cells in the adult pancreas. In addition to
ducts, cells expressing markers for acinar (Ptf1a (Pan et al., 2013;
Baeyens et al., 2014), carboxypeptidase A (Zhou et al., 2008), or elastase
(Baeyens et al., 2014)) or endocrine cells (insulin (Dor et al., 2004) or
glucagon (Thorel et al., 2010)) have been shown to give rise to new
beta cells in the adult murine pancreas. Together, these results suggest
that there are multiple mechanisms by which beta cells can be
replenished from different cellular sources in the adult pancreas. How-
ever, the aforementioned in vivo lineage-tracing studies did not directly
address properties of multi-potentiality and self-renewal—two criteria
necessary to deﬁne a stem cell.To investigate progenitor cells in the adult pancreas, we and others
have turned to in vitro single cell analysis. We designed unique 3D col-
ony assays that allow quantitative analyses of single progenitor-like
cells from adult murine pancreas. Using these assays, we found that
the adult murine pancreas contains tripotent progenitor cells that are
capable of multi-lineage differentiation and robust self-renewal in
vitro (Jin et al., 2013; Fu et al., 2013; Jin et al., 2014). These progenitor-
like cells were named “pancreatic colony-forming units” (PCFUs). Con-
sistent with our ﬁndings, other laboratories conﬁrmed that dissociated
single cells from the adult pancreas of mice (Huch et al., 2013; Dorrell
et al., 2014) and humans (Lee et al., 2013) can be propagated in high
concentrations (N33% vol/vol) of Matrigel in vitrowhere they generate
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Fu et al., 2013; Jin et al., 2014). Together, these results demonstrate that
single cells with the capacities for self-renewal andmulti-lineage differ-
entiation in vitro are present in the adult pancreas. However, these PCFU
progenitor cells remain poorly characterized.
One major roadblock to effective characterization of PCFUs is that
they constitute a minor population in the adult pancreas (~1% in
2–4month-oldmice) (Jin et al., 2013; Jin et al., 2014). Thus, puriﬁcation
of these progenitor cells is needed. Previously, a transgenic mouse
model was used for enrichment of PCFUs (Jin et al., 2013). In this
mouse model, expression of enhanced green ﬂuorescence protein
(EGFP) reporter was driven by Sox9 regulatory loci (75 kb upstream
and 150 kb downstream sequences) in a CD1 out-bred background
(Formeister et al., 2009). However, this strategy prohibits enrichment
of PCFUs from other mousemodels. Therefore, identiﬁcation of cell sur-
face markers expressed by PCFUs could lead to an alternative enrich-
ment method. CD133 (prominin 1) is a cell-surface marker commonly
used to enrich various stem cells from adult tissues (Miraglia et al.,
1997), and adult pancreatic ducts of humans and mice express CD133
(Hori et al., 2008; Lardon et al., 2008; Oshima et al., 2007; Sugiyama
et al., 2007). Our prior work demonstrated that CD133+, but not
CD133− pancreatic cells from adult C57Bl/6 (B6) mice, contained
PCFUs (Jin et al., 2013; Jin et al., 2014). However, only one in about
twenty pancreatic CD133+ cells was a PCFU (Jin et al., 2014), consistent
with a recent report (Dorrell et al., 2014).
The goal of this studywas to identify an additional cell-surfacemark-
er that, when combined with CD133, could further distinguish and en-
rich PCFUs. Cell surface markers that were previously known to enrich
non-pancreas progenitor cells, including CD71 (transferrin receptor),
were screened. CD71 transports iron from the extracellular space into
cells, and higher levels of CD71 expression are detected in erythroid
progenitor cells (Fraser et al., 2007) as well as in some cancer cells
(Keysar & Jimeno, 2010). The adult pancreas expresses CD71 (Gatter
et al., 1983); however, its role in the pancreas has not been character-
ized. Here, we report that CD71 expression status fractionates pancreat-
ic CD133+ ductal cells in adult mice. Among the subpopulations,
CD133highCD71low cells are the most enriched for PCFUs, and approxi-
mately one in three CD133highCD71low cells is a PCFU. This enriched
population will enable further studies on putative pancreas stem and
progenitor cells in vivo.2. Results
2.1. Expression of CD133 and CD71 in the adult murine pancreas
CD133 is expressed by the ductal cells of the adult pancreas (Hori
et al., 2008; Lardon et al., 2008; Oshima et al., 2007; Sugiyama et al.,
2007). We used ﬂow cytometry analysis to screen other known cell-
surface markers to determine their ability to fractionate adult CD133+
pancreatic cells. CD71 was found to divide CD133+ ductal cells into
three major subpopulations: CD133+CD71−, CD133highCD71low, and
CD133lowCD71low cells, as indicated by regions (R) 1 to 3, respectively
(Fig. 1A), suggesting heterogeneity of ductal cells.
Quantitative (q) RT-PCR analysis of freshly sorted cells indicated that
cells in both R1 and R2 expressed higher levels of ductal genes (Krt19,
Krt7 and Sox9) and Pdx1 compared to unsorted cells (Fig. 1B). Compared
to R2, R1 cells expressed higher levels of endocrine markers, Insulin1
and Glucagon (Fig. 1B). Because the lower limit of the R1 gate was
close to the double negative cells, some endocrine cells may have
been contaminated during sorting. In the subsequent RNA-seq experi-
ments (see below), the lower boundary of the sorting gate for R1
was moved upward, and as a result no difference in the expression of
Insulin1 and Glucagon between R1 and R2 cells was observed (Supple-
mentary Table 1). R3 cells did not express signiﬁcant levels of the afore-
mentioned pancreatic lineage markers (Fig. 1B).To further conﬁrm the expression of CD71 in the ducts, immunohis-
tochemical staining on sections of adult murine pancreas was per-
formed. As expected, CD133 was expressed in the ductal structures
(Fig. 1C; dotted line). CD71 was found to co-localize with CD133 in
the ducts (Fig. 1C). For additional conﬁrmation, ductal cells that
expressed Sox9 also stained positive for CD71 (Fig. 1D), again demon-
strating that CD71 was expressed in the ductal region.
Pdx1 protein was detected in the CD133+ ductal cells by double im-
munostaining analyses (Fig. 1E), although the overall intensities of Pdx1
was lower in ducts compared to that in the islet cells, which are known
to express Pdx1 (Ohlsson et al., 1993). Interestingly, the staining inten-
sities for Pdx1 or CD133 varied among individual ductal cells (Fig. 1E),
again suggesting heterogeneity of ductal cells.
To further characterize R1 and R2 ductal cells, genome-wide gene
expression analysis using RNA-seq was performed (Supplementary
Fig. 1A). Compared to R1, R2 cells expressed higher levels of several duc-
tal and epithelial cell markers including Krt19 (Fig. 1F), consistent with
the above qRT-PCR analysis (Fig. 1B). R2 cells expressed higher levels of
cyclin A2, a positive regulator of cell cycle gene (Fig. 1F), suggesting that
R2 cells may be ready for proliferation and forming colonies. Indeed, R2
but not R1 ductal cells gave rise to colonies in culture (see below).
Pathway analysis of the RNA-seq data revealed that R2 and R1 cells
have propensities for cell migration and immune response, respectively
(Supplementary Fig. 1B). Taken together, these results demonstrate
that, unlike the Sox9/EGFP mice used in our previous study (Jin et al.,
2013), CD71 expression status fractionates pancreatic CD133+ ductal
cells into subpopulations in adult mice and that ductal cells are
heterogeneous.
Most CD133− cells expressed CD71 at higher levels (Fig. 1A; R4) or
at undetectable levels (double negative cells). Approximately 80% of
CD133−CD71high (R4) cells expressed TER119 (Supplementary Fig. 2),
an erythroid lineage-speciﬁc marker (Okada et al., 1991), suggesting
that R4 contains mostly red blood cells or their immediate precursors.
Red blood cells were lysed before antibody staining and ﬂow cytometry
analysis. This manipulation resulted in a reduced percentage of
CD133−CD71high (R4) cells (Supplementary Fig. 3), further conﬁrming
that R4 contains red blood cells.
2.2. Murine adult pancreatic CD133highCD71low (Region 2) cells are most
enriched for colony-forming progenitors
Previously, we devised two pancreatic colony assays, one containing
Matrigel and the other a laminin hydrogel, which support the formation
of Ring or Endocrine/Acinar colonies, respectively (Supplementary
Fig. 4) (Jin et al., 2013). These colony types aremorphologically distinct.
Ring colonies are cystic and contain mostly ductal-like cells (Jin et al.,
2013; Jin et al., 2014); whereas, Endocrine/Acinar colonies are small
and compact, composed mostly of endocrine- and acinar-like cells and
fewer ductal cells (Jin et al., 2013). A single progenitor cell capable of
giving rise to a Ring or an Endocrine/Acinar colony is designated as a
PCFU-Ring or a PCFU-Endocrine/Acinar, respectively.
Next, we tested which subpopulations contained PCFUs-Ring or
PCFUs-Endocrine/Acinar (Fig. 2). Freshly sorted cells were plated into
Matrigel or laminin hydrogel colony assays, and the resulting colonies
were counted. CD133−CD71− cells did not form Ring or Endocrine/
Acinar colonies, consistent with our previous studies showing that
CD133− cells are devoid of PCFUs (Jin et al., 2013; Jin et al., 2014). In
contrast, after three weeks in Matrigel colony assay, a plating of 2500
CD133highCD71low (R2) cells resulted in 816 ± 19 Ring colonies
(Fig. 2A & B), demonstrating that 32 ± 1% of the CD133highCD71low
cells were PCFUs-Ring (Fig. 2C).
In our previous studies, Endocrine/Acinar colonies formed when
freshly-sorted CD133+Sox9/EGFP+ cells were ﬁrst expanded inMatrigel
for 3 weeks to generate Ring colonies, which were subsequently dissoci-
ated and re-plated into laminin hydrogel for 10 days (Jin et al., 2013).
These Endocrine/Acinar colonies grown in the secondary laminin-
Fig. 2. The CD133highCD71low subpopulation is most enriched for colony-forming progenitor cells. (A & D) Photomicrographs of representative Ring (A) or 1° Endocrine/Acinar (D) colonies
viewed under a phase-contrast microscope with visible light illumination. (B & C) Sorted R1 to R4 cells, as indicated in Fig. 1A, were plated into the Matrigel colony assay. After 3 weeks, the
resulting Ring colonies were counted and the colony-forming efﬁciency (number of colonies divided by the total number of cells plated) determined. Data represent mean and standard devi-
ation from triplicate wells. (E & F) Same as in B & C, except that sorted cells were plated in the laminin-hydrogel colony assay. Endocrine/Acinar colonies were counted 10 days post-plating.
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colonies. Similarly, 2° Endocrine/Acinar colonies formed after Ring colo-
nies derived fromCD133highCD71low cellswere dissociated and re-plated
into laminin hydrogel (Supplementary Fig. 5). When sorted CD133-
highCD71low cells were directly plated into the laminin-hydrogel assay
at 25,000 cells per well, 256 ± 18 Endocrine/Acinar colonies were de-
tected (Fig. 2D & E). These Endocrine/Acinar colonies grown in the pri-
mary laminin-hydrogel culture were designated as primary (1°)
Endocrine/Acinar colonies. The colony-forming efﬁciency of CD133-
highCD71low (R2) cells for 1° Endocrine/Acinar colonies was 1 ± 0.1%
(Fig. 2F). In contrast, R1, R3 and R4 cells did not have signiﬁcant
colony-forming capacity compared to unsorted cells (Fig. 2B & E). To-
gether, these results demonstrate that both PCFUs-Ring and 1° PCFUs-
Endocrine/Acinar progenitors are enriched in the CD133highCD71low
(R2) cell fraction. The CD133highCD71low (R2) cells represented 2.4 ±
1.9% (n = 7; ranges 0.6–6.0%) of total dissociated pancreatic cells.2.3. Ring colonies derived from the CD133highCD71low (R2) cells are ductal-
like, express progenitor markers, and contain self-renewing colony-forming
cells
To test the lineage compositions of individual Ring or 1° Endocrine/
Acinar colonies, microﬂuidic qRT-PCR analyses were performed (Fig. 3A
& B). Microﬂuidic qRT-PCR has a reaction volume in the nano-liter
range, permitting gene expression analysis from a single colony (Jin
et al., 2013;Narsinh et al., 2011). Colonieswere individually handpicked
under directmicroscope visualization (n=21 per group). Expression of
a panel of genes indicative of pancreatic progenitor, ductal, endocrine,
and acinar lineages was analyzed.
Individual Ring colonies expressed higher levels of ductal (Sox9
and Muc1) and progenitor cell markers (Ngn3 and Pdx1) (Fig. 3A & B),
compared to 1° Endocrine/Acinar colonies. Transmission electron mi-
croscopy revealed multi-lobed nuclei (arrow) and microvilli (arrow
Fig. 3. CD133highCD71low cell-derived Ring or 1° Endocrine/Acinar colonies express higher levels of duct and progenitor or endocrine and acinar cell markers, respectively.
(A & B) Microﬂuidic qRT-PCR analyses on individually handpicked colonies. The results in (A) are expressed as heat maps; whereas, (B) shows expression levels relative to β-actin.
Each column or bar represents a single colony.
45L. Jin et al. / Stem Cell Research 16 (2016) 40–53head) (Fig. 4A), indicating a ductal cell phenotype.Whole-mount immu-
nostaining analysis conﬁrmed protein expression of Ngn3 and Pdx1 in
Ring colonies derived from CD133highCD71low (R2) cells (Fig. 4B & C;
nucleus staining). These results are consistent with our prior ﬁndingsthat Ring colonies, derived either from CD133+Sox9/EGFP+ from CD1
outbred mice (Jin et al., 2013) or CD133+ cells from B6 inbred mice
(Jin et al., 2014), are predominantly ductal-like cells that express progen-
itor cell markers.
Fig. 4. Cells in Ring colonies display ultra-structures consistent with ductal phenotype, and some cells express progenitor markers. (A) Transmission electronmicroscopy of a Ring colony
derived from CD133highCD71low cells. Arrow indicates indentation of the nuclear membrane. Arrow head indicates microvilli. These ﬁne structures are ductal characteristics.
(B & C) Whole-mount immunostaining of pooled Ring colonies showing protein expression of Ngn3 (B) and Pdx1 (C).
46 L. Jin et al. / Stem Cell Research 16 (2016) 40–53Three-week-old Ring colonies continued to express CD133 and CD71
(Fig. 3A & B), suggesting that the originating CD133highCD71low (R2)
cells may have either given rise to ductal cells or self-renewed as pro-
genitors. To test whether the freshly sorted CD133highCD71low (R2)cells could self-renew, 3-week-old primary Ring colonies (n = 8)
were individually handpicked, dissociated, and re-plated into Matrigel
assays for a total of six passages (Fig. 5). All eight primary Ring colonies
initiated secondary and subsequent colonies (Fig. 5), indicating that
47L. Jin et al. / Stem Cell Research 16 (2016) 40–53single PCFUs-Ring contained in the CD133highCD71low (R2) population
were capable of self-renewal in vitro.2.4. Primary “Endocrine/Acinar” colonies derived from the CD133highCD71low
population express higher levels of endocrine and acinar markers, and lower
levels of ductal markers compared to Ring colonies
In contrast to Ring colonies, 1° Endocrine/Acinar colonies expressed
higher levels of endocrine (Insulin1, Insulin2, Glucagon) and acinar
(Amylase 2A) genes, and lower levels of ductal (Sox9,Mucin1) genes in
single-colony RT-PCR analyses (Fig. 3A & B). Protein expression of
Amylase (an acinar marker) (Fig. 6A) in whole-mounted 1°
Endocrine/Acinar colonies was detected but did not co-localize with
C-peptide+ cells (a surrogate marker for de novo synthesized insulin).
Similarly, Krt19-expressing ductal cells did not co-stain with insulin
(Fig. 6B). Surprisingly, double immunostaining of glucagon and
C-peptide in 1° Endocrine/Acinar colonies revealed that cells expressing
C-peptidewere all positive for glucagon (Fig. 6C; yellow color). This is in
contrast to our prior results on the 2° Endocrine/Acinar colonies that
express single hormones (Jin et al., 2013). Transmission electron mi-
croscopy showed both insulin-like and non-insulin granules within
cells in CD133highCD71low (R2)-derived 1° Endocrine/Acinar colonies
(Fig. 6D), further conﬁrming the double-hormonal phenotype.
CD133highCD71low (R2)-derived 1° Endocrine/Acinar colonies
expressed higher levels of several beta cell maturation markers, such
as Glut2, Glucokinase, Pcsk1 and Pcsk2, compared to Ring colonies
(Fig. 3A & B). Therefore, we tested whether these 1° Endocrine/Acinar
colonies were glucose responsive in C-peptide secretion in vitro
(Fig. 6E). Pooled (~1000) 1° Endocrine/Acinar colonies released 1.43-
fold more C-peptide into the media when presented with 16.7 mM
compared to 2.5 mM D-glucose (Fig. 6E). When colonies were bathed
with 16.7 mM D-glucose plus 10 mM theophylline (a cAMP potentia-
tor), 2.13-fold more C-peptide was released (Fig. 6E). Intracellular
C-peptide levels in these colonies (0.65 ± 0.32 μg/g proteins) were
~3700 fold lower than that in adult murine islets (2427 ± 1395 μg/g
proteins). Thus, despite the simultaneous expression of insulin
and glucagon as well as the low intracellular C-peptide levels,
CD133highCD71low (R2)-derived 1° Endocrine/Acinar colonies are func-
tional in C-peptide secretion in vitro.Fig. 5. Single PCFU-Ring self-renews and generates secondary and subsequent Ring colo-
nies in vitro. Upper panel: A schematic representation of a re-plating experiment. Sorted
CD133highCD71low cells were plated into Matrigel-containing culture. Three weeks later,
a primary Ring colony was hand-picked, dissociated into single cell suspension, and re-
plated into Matrigel-containing culture for a total of 6 passages. Lower panel: Serial re-
plating of an individually hand-picked primary Ring colony (n= 8) generated secondary
and subsequent Ring colonies in Matrigel-containing culture.2.5. Primary Endocrine/Acinar colonies give rise to ductal, acinar,
C-Peptide+Glucagon−, and C-Peptide−Glucagon+ cells in vivo
Attempts to dissociate and re-plate 1° Endocrine/Acinar colonies
into 2° laminin hydrogel culture did not result in the formation of 2°
Endocrine/Acinar colonies. In the positive control experiment, dissociat-
ed Ring colonies did form 2° Endocrine/Acinar colonies. These results
suggest that the current laminin hydrogel culture condition may not
support the development of the 2° Endocrine/Acinar colonies from the
1° Endocrine/Acinar colonies. To test whether an in vivo environment
may allow further development of pancreatic lineages, 10-day-old
1° Endocrine/Acinar colonies were placed underneath the renal
capsules of streptozotocin-induced diabetic mice (~12,000 colonies
per kidney; n = 2). The grafts were examined 5 weeks post-
transplantation (Fig. 7A). By week 5, cells were either insulin+glucagon−
or insulin−glucagon+ as shown by immunohistochemical staining
(Fig. 7B). In addition, Krt19+ ductal cells and Amylase+ acinar cells
were also detected in the grafts (Fig. 7B). The ductal-like cells were
most likely originated from donor cells because they were located inside
the grafts (Fig. 7A, H&E staining and Fig. 7B, blue box); however, further
conﬁrmation is required because kidney tubules are known to express
KRT19 (Skinnider et al., 2005). Taken together, these results demonstrate
that 1° Endocrine/Acinar colonies derived from the CD133highCD71low
population have tri-lineage differentiation potential in vivo and are capa-
ble of giving rise to insulin+glucagon− cells.
3. Discussion
We report that sorting for CD133highCD71low cells enriches PCFU
progenitors that form Ring or 1° Endocrine/Acinar colonies in Matrigel
or laminin hydrogel, respectively. The enrichment of these PCFUs is
achieved using a strategy that has been successful in purifying adult he-
matopoietic stem cells (HSCs) (Spangrude et al., 1988).MurineHSCs are
often designated as lineage negative (Lin−), indicating that they do not
express the cell-surface markers CD4, CD8, B220, Mac-1, Gr-1, or
TER119 for differentiated blood cells (Spangrude et al., 1988). Addition-
almarkers, including stem cell antigen (Sca-1) (Spangrude et al., 1988),
CD117 (c-Kit) (Okada et al., 1991), CD48, and CD150 (Kiel et al., 2005),
have been identiﬁed to either positively or negatively select HSCs. About
one in two Lin−Sca-1+c-kit+CD48−CD150+ bone marrow cells is a
HSC (Kiel et al., 2005).
CD133has been shown to positively enrich progenitors from embry-
os and neonates of murine (Hori et al., 2008; Oshima et al., 2007;
Sugiyama et al., 2007; Ghazalli et al., 2015) and human (Sugiyama
et al., 2007) pancreas, as well as from adult human pancreas (Lee
et al., 2013). We (Jin et al., 2014) and others (Dorrell et al., 2014) have
previously shown that pancreatic progenitor cells from adult mice can
be enriched by CD133 selection. However, the cell culture techniques
reported by others were more difﬁcult to enumerate colonies. Cells
were mixed in high concentrations (N33% vol/vol) of Matrigel and
placed only at the edge of the culture well. After solidiﬁcation, the
Matrigelwas thicker at theperiphery than towards the center of the cul-
ture dish. When viewed under a phase-contrast light microscope, the
images of the resulting colonies were largely overlapping, preventing
effective counting. Quantiﬁcation of colony was achieved by sparse
organoid plating or single cell deposition methods (Dorrell et al.,
2014), which were labor-intensive and resource-consuming. In con-
trast, the methylcellulose-containing semi-solid media that we used
allowed us to evenly spread Matrigel and colonies across the culture
well. In addition, a gridwas attached underneath the culturewell to fur-
ther facilitate accurate numeration by avoiding double counting
(Winkler et al., 2011). Using our quantitative assays, we ﬁnd that ap-
proximately one in three adult pancreatic CD133highCD71low cells is a
PCFU-Ring (Fig. 2C), compared to ~1 in 100 pre-sorted pancreatic cells
(Jin et al., 2013; Jin et al., 2014) (Fig. 2C), which translates to a 33-fold
enrichment. The efﬁciency of formation of Ring colonies from
Fig. 6. Primary Endocrine/Acinar colonies express acinar, ductal, and endocrine markers and are glucose responsive in vitro. (A–C) Whole-mount immunostaining of 10-day-old 1°
Endocrine/Acinar colonies. Note that C-peptide-expressing cells also express glucagon. (D) Transmission electron microscopy of a cell in a 1° Endocrine/Acinar colony that contained
two types of granules. Red and green arrows indicate insulin-like and non-insulin granules, respectively. (E) Primary Endocrine/Acinar colonies were pooled and subjected to sequential
in vitro incubation with designated levels of D-glucose and/or theophylline, a cAMP potentiator. Murine adult islets are positive controls.
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Fig. 7. Primary Endocrine/Acinar colonies give rise to acinar, ductal, insulin+glucagon−, and insulin−glucagon+ cells in diabeticmice. (A) Left: Photomicrograph of a kidney 5weeks after
transplantation of 12,000 1° Endocrine/Acinar colonies. Right: Hematoxylin & Eosin (H & E) staining of the graft. (B) Double immunohistochemical staining of the graft with antibodies
against C-peptide and Glucagon or Amylase and Krt19.
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50 L. Jin et al. / Stem Cell Research 16 (2016) 40–53CD133highCD71low cells has now reached ~30% (Fig. 2C), compared
to ~5% from CD133+ selection alone in B6 mice (Jin et al., 2014)
and ~15% from CD133+Sox9/EGFP+ cells from CD1 mice (Jin et al.,
2013). Importantly, the use of commercially-available antibodies rather
than transgenic mice will enable the characterization of adult PCFUs in
many laboratories.
The efﬁciency of formation of 1° Endocrine/Acinar colonies from un-
sorted pancreatic cells is only ~0.1% (Fig. 2F). CD133highCD71low cells
enrich 1° PCFUs-Endocrine/Acinar about 8-fold compared to unsorted
cells (Fig. 2F), and the colony-forming efﬁciency for 1° Endocrine/Acinar
colonies from CD133highCD71low cells reaches ~1% (Fig. 2F).
As mentioned, Ring colonies in our previous studies developed from
sorted CD133+ (Jin et al., 2014) or CD133+Sox9/EGFP+ cells (Jin et al.,
2013). Consistent with the characteristics of those colonies, the Ring
colonies derived from CD133highCD71low cells also express higher levels
of ductal (Fig. 3B) and pancreatic progenitor cell markers, such as Pdx1
or Ngn3 (Fig. 3B), compared to 1° Endocrine/Acinar colonies. Similar to
previous results (Jin et al., 2014), cells from a handpicked Ring colony
derived from CD133highCD71low cells generate secondary and subse-
quent Ring colonies over six serial passages in Matrigel (Fig. 5), demon-
strating the capacity for self-renewal of the originating, single PCFU-
Ring.
A new observation from the current study is that cells in 10-day-old
1° Endocrine/Acinar colonies grown in laminin hydrogel express insulin
and glucagon simultaneously (Fig. 6C and D). This is in contrast to the
insulin+glucagon− or insulin−glucagon+ cells in the 2° Endocrine/
Acinar colonies that we identiﬁed in a previous report (Jin et al.,
2013). Previously, freshly sorted CD133+Sox9/EGFP+ cells were initial-
ly plated into the Matrigel assay, with or without exogenous
R-spondin1, aWnt signaling agonist, for 3 weeks to generate Ring colo-
nies. When Ring colonies were collected and dissociated into single cell
suspension and re-plated into laminin hydrogel for an additional
10 days, the 2° Endocrine/Acinar colonies that formed expressed either
insulin or glucagon (Jin et al., 2013). These results suggest that our for-
mer two-step culture method, in which the PCFUs were expanded prior
to the induction of endocrine differentiation, permitted more time for
the progenitor cells to develop and mature into single hormonal posi-
tive cells. The 1° Endocrine/Acinar colonies derived from freshly sorted
CD133+Sox9/EGFP+ cells were not examined in the previous study (Jin
et al., 2013) because of the low incidence of 1° Endocrine/Acinar
colonies.
Five weeks post-transplantation into diabetic mice, CD133high
CD71low cell-derived, 10-day-old 1° Endocrine/Acinar colonies gave
rise to insulin+glucagon− and insulin−glucagon+ cells aswell as ductal
and acinar cells (Fig. 7). These results demonstrate that CD133high
CD71low cells are progenitor cells with tri-lineage differentiation capac-
ity. An in vivo study reported by Thorel et al. (Thorel et al., 2010) showed
that severe beta-cell injury (N99% destruction) led to the formation of
insulin+glucagon+ cells, followed by the appearance of insulin+-
glucagon− cells. Because the regenerated beta cells were lineage-
traced from glucagon-expressing cells, it was concluded that alpha
cells trans-differentiated into beta cells (Thorel et al., 2010). It is possi-
ble that CD133highCD71low cells described in this study differentiated
into insulin+glucagon− cells in vivo via an insulin+glucagon+ interme-
diate cell stage in vitro. However, further lineage tracing experiments
are needed to test this hypothesis.
In summary, we report that adult pancreatic progenitor cells from
B6, non-transgenic mice can be highly enriched using two cell-surface
markers and live-cell sorting. Approximately 30 and10-fold enrichment
of PCFUs-Ring and 1° PCFUs-Endocrine/Acinar, respectively, in
CD133highCD71low cells were achieved compared to unsorted cells. It
should be noted that only in vitro self-renewal andmulti-lineage differ-
entiation by the CD133highCD71low cells are demonstrated in the current
study, and these results do not prove that progenitor cells exist in vivo in
the adult pancreas. Further conﬁrmation will require examining multi-
lineage reconstitution and self-renewal of CD133highCD71low cellstransplanted into an animal model with a severely injured pancreas.
Finally, the results presented in this study have direct implications for
in vitro generation of glucose-responsive beta-like cells to treat diabetes
patients.
4. Materials and methods
4.1. Mice
C57BL/6J (donors; 2–4 months old) (The Jackson Laboratory, Bar
Harbor, ME, USA) and NOD–SCID (recipients; 2 months old) (Charles
River Laboratory, Wilmington, MA, USA) were used in this study. All
miceweremaintained under speciﬁc pathogen-free conditions, and an-
imal experiments were conducted according to the Institutional Animal
Care and Use Committee at the City of Hope.
4.2. Preparation of Single Cell Suspensions
Murine pancreata were dissected, cleared of fat tissue under a dis-
secting microscope, and rinsed three times in cold DPBS containing
0.1% bovine serum albumin, penicillin, and streptomycin (PBS/BSA).
Whole pancreata, in a dry petri dish placed on ice, were chopped
using spring scissors for approximately 2 min or until ﬁnely minced.
The triturated tissue was transferred to a 15 ml conical tube, washed
once, resuspended in PBS/BSA containing collagenase B (2–4 mg/ml)
(Roche, Mannheim, Germany) and DNase І (2000 U/ml) (Calbiochem,
Darmstadt, Germany), and incubated at 37 °C for 20min to yield amost-
ly single cell suspension. To hasten the digestion, tissue was gently
disrupted every 5–10 min using a 16G syringe needle. Cells were then
washed twice in cold PBS/BSA supplemented with 2000 U/ml DNase I,
which was used to prevent re-aggregation of dissociated cells, and ﬁl-
tered through a 40 μm nylon mesh (BD Biosciences, San Jose, CA, USA)
before antibody staining. Between 3 and 5 million cells per pancreas
can be recovered from adult B6 mice.
4.3. Flow Cytometry and Cell Sorting
Single cell suspensions were ﬁrst incubated with anti-mouse CD16/
32 (10 μg/ml) (BioLegend, SanDiego, CA, USA) for 5min on ice to dimin-
ish nonspeciﬁc binding. Biotin-conjugated anti-mouse CD133 (clone
13A4; 5 μg/ml) (eBioscience, San Diego, CA, USA) and phycoerythrin/
Cy7 (PECy7)-conjugated anti-mouse CD71 (clone RI7217; 5 μg/ml)
(BioLegend) antibodies were added to cells. Cells were incubated for
20 min on ice, washed twice, and then treated with streptavidin-
labeled allophycocyanin (APC) (2 μg/ml) (BioLegend) for 15 min on
ice, washed twice, and resuspended in PBS/BSA/DNase I containing
DAPI (0.2 μg/ml). Control antibodies were biotin-conjugated rat immu-
noglobulin (Ig)G1 (5 μg/ml) (eBioscience) and PE/Cy7-conjugated rat
IgG1 (5 μg/ml) (BioLegend). For Supplementary Figs. 1 & 2, ﬂuorescein
isothiocyanate (FITC)-conjugated anti-mouse TER119 (clone TER119;
5 μg/ml) (Biolegend) was added to the primary antibody mix. Flow cy-
tometry analysis was performed on an Accuri C6 or an LSRFortessa Cell
Analyzer (Becton Dickinson, San Jose, CA, USA). Acquired ﬂow data
were analyzed with software provided by Accuri or FloJo (TreeStar,
Ashland, OR, USA). Cell sorting was performed on an Aria-special
order research product (SORP) (Becton Dickinson). All analyses includ-
ed an initial gating of forward (FSC) and side (SSC) scatter to exclude
debris. In cell sorting experiments, doublets were excluded by gating
out high pulse-width cells, and live cells were selected by DAPI negative
staining (Supplementary Fig. 6). The purity of the sorted populationwas
routinely N95%.
4.4. Colony Assays
Sorted cells were resuspended at a density of 2.5 × 103 cells/well/
0.5 ml for the Matrigel assay or 2.5 × 104 cells/well/0.5 ml for the
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media contained DMEM/F12media, 1%methylcellulose (Sinetsu Chem-
ical, Tokyo, Japan), 50% conditionedmedia frommouse embryonic stem
cell derived pancreatic-like cells, 5% fetal calf serum (FCS), 10 mmol/l
nicotinamide (Sigma, St. Louis,MO,USA), 10 ng/ml human recombinant
activin B, 0.1 nmol/l exendin-4 (Sigma), and 1 ng/ml vascular endothe-
lial growth factor-A (VEGF) (Sigma).When indicated, either 5%Matrigel
or 100 μg/ml of laminin hydrogel (Jin et al., 2013)was added tomedia to
generate Ring or Endocrine/Acinar colonies, respectively. Cells were
plated in 24-well ultra-low protein-binding plates (Corning, Corning,
NY, USA) and incubated in a humidiﬁed 5%CO2 atmosphere. Ring or En-
docrine/Acinar colony numbers were counted 3 weeks or 10 days after
plating, respectively. For serial re-plating experiments, individual Ring
colonieswere handpicked anddissociated into single cells by incubating
with 0.25% trypsin-EDTA at 37 °C for 5 min, followed by gentle pipet-
ting. Single cells were then re-plated in the Matrigel assay as described
above.
4.5. Conventional or microﬂuidic quantitative reverse transcription-
polymerase chain reaction (qRT-PCR)
Total RNA extraction, reverse transcription, and conventional qRT-
PCR analyses were performed as previously described (Jin et al.,
2013). Duplicate samples were used in all analyses. Microﬂuidic qRT-
PCR was performed using the BioMark™ 48.48 Dynamic Array system
(Fluidigm, South San Francisco, CA, USA). Single colonies were lifted
one by one from the methylcellulose-containing medium under direct
microscopic visualization using a 10 μl Eppendorf pipette, collected in
reaction buffer (10 μl), and pre-ampliﬁed (14 cycles) according to the
manufacturer's instructions (Fluidigm). Ampliﬁed cDNA was loaded
onto a 48.48 Dynamic Array using theNanoFlex integrated ﬂuidic circuit
(IFC) controller (Fluidigm). Threshold cycle (Ct), as a measure of ﬂuo-
rescence intensity, was determined by the BioMark PCR analysis soft-
ware (Fluidigm) and expressed as a heat map or delta Ct compared to
β-actin. All experiments were performed with negative (water) and
positive (adult C57BL/6J pancreatic cells) controls. TaqMan probes
(Life Technologies, Grand Island, NY, USA) and their catalog numbers
are listed in Supplementary Table 2.
4.6. Electron Microscopy
Single colonies were collected, pooled, and ﬁxed in 2% glutaralde-
hyde +0.1 M Cacodylate buffer [Na(CH3)2AsO2·3H2O; pH 7.2] at 4 °C
overnight. Colonies were washed three times with 0.1 M Cacodylate
buffer (pH 7.2), post-ﬁxed with 1% OsO4 in 0.1 M Cacodylate buffer
for 30 min, and washed three times with 0.1 M Cacodylate buffer. The
sampleswere then dehydrated, embedded in Eponate, and polymerized
at 64 °C for 48 h. Ultrathin sections (70-nm thickness) were cut using a
Leica ultramicrotome (Leica Biosystems, Wetzlar, Germany) with a dia-
mond knife, transferred to 200-mesh EMgrids, and stainedwith 2% ura-
nyl acetate in 70% ethanol for 1 min followed by treatment with
Reynold's lead citrate for 1 min. Electron microscopy was performed
on a Tecnai 12 transmission electron microscope (FEI, Hillsboro, OR,
USA) equipped with an Ultrascan 2 K CCD camera (Gatan, Pleasanton,
CA, USA).
4.7. Immunostaining
For frozen sections, preﬁxed-pancreata were cryoprotected in
30% sucrose in PBS, embedded in O.C.T. (Sakura Finetek, Torrance,
CA, USA), and sliced at 10 μm thickness. For parafﬁn-embedded
formalin-ﬁxed tissues, samples were cut to 5 μm thickness, de-
waxed in xylene bath for 15min, rehydrated in ethanol, and antigens
retrieved by heating in a microwave oven for 10 min in 200 ml of so-
dium citrate buffer. Samples were incubated with blocking buffer
supplemented with 5% donkey serum and 0.1% TritonX-100 at 4 °Covernight before addition of primary antibodies. For whole-mount
immunohistochemistry, colonies were manually picked, pooled,
ﬁxed in 4% paraformaldehyde at 4 °C overnight, and incubated with
blocking buffer supplemented with 5% donkey serum and 0.1%
TritonX-100 at 4 °C overnight. Primary antibodies were as listed in
Supplementary Table 3 and detected with donkey-raised secondary
antibodies conjugated to Cy3, Cy5, DyLight488, or AlexaFlour647
(Jackson Immunoresearch, West Grove, PA, USA). Images were cap-
tured on a Zeiss LSM510 META NLO Axiovert 200 M inverted micro-
scope, and ﬁgures prepared with LSM Image Browser software (Carl
Zeiss, Germany).
4.8. In vitro glucose challenge assay and intracellular C-peptide
measurement
Primary Endocrine/Acinar colonieswere pooled and incubated over-
night with Krebs-Ringer solution (KRBH; 129 mM NaCl, 4.8 mM KCl,
2.5 mM CaCl2, 1.2 mM KH2PO4, 1.2 mM MgSO4, 5 mM NaHCO3,
10 mM HEPES, 0.1% bovine serum albumin) containing 10% FCS and
2.5 mM D-glucose. The next day, colonies were washed three times
with KRBH containing 2% FCS and 2.5 mM D-glucose and then sequen-
tially incubated with 2.5 mM D-glucose, 16.7 mM D-glucose, and
16.7 mM D-glucose plus 10 mM theophylline (37 °C, 0.5 ml/well, 2 h).
The C-peptide concentration in the buffer was measured using the mu-
rine C-peptide ELISA kit, U-Type (Shibayaji Co., Gunma, Japan), which
has a detection limit of 30 pg/ml. The stimulation was expressed as
the fold change of C-peptide concentrations in buffer from the second
and third treatments compared to the ﬁrst treatment of the same well.
To measure intracellular C-peptide, cells were lysed in RIPA buffer
(Sigma) and the resulting lysate was analyzed for levels of total protein
by BCA protein assay (ThermoFisher Scientiﬁc,Waltham,MA, USA) and
C-peptide by ELISA as described above.
4.9. In vivo transplantation
Primary Endocrine/Acinar colonies were handpicked, pooled, and in-
cubated in recovery solution (BD Bioscience) for 1 h on ice. Intact colo-
nies released from the semisolid media were washed and collected for
transplantation. NOD–SCID mice (8 week-old males) were injected
with streptozotocin (STZ; 50 mg/kg body weight; freshly made in
0.05 M citrate buffer, pH 4.5) for 3 consecutive days to induce diabetes
(Gerling et al., 1994). Hyperglycemia was deﬁned as N200 mg/dl and
measured by OneTouch Ultra2 glucometer (LifeScan, Milpitas, CA, USA)
starting 1 week after the last STZ injection. Approximately 12,000
Endocrine/Acinar colonies were placed under the renal capsule per
mouse (n = 2). Grafts were examined 5 weeks post-transplantation by
immunohistochemical staining of formalin-ﬁxed parafﬁn-embedded
tissue sections.
4.10. RNA-seq analysis
Reads were aligned to the mouse genome (build mm10). Reads per
kilobase per million (RPKM) (Mortazavi et al., 2008) were calculated
for RefSeq transcripts (Pruitt et al., 2012) using an expectation-
maximization algorithm in Partek Genomics Suite (Version 6.6) (Partek,
St. Louis, MI, USA) (Xing et al., 2006). RPKM values were then further
normalized via log2 transformation following the addition of a scaling
factor of 0.1 (Warden et al., 2014). Fold-change values were calculated
on a linear scale based on the least-squares mean. P values were calcu-
lated by one-way ANOVA using the normalized RPKM values. False dis-
covery rate (FDR) valueswere calculated using themethod of Benjamini
and Hochberg (Benjamini & Hochberg, 1995). Transcripts were deﬁned
as differentially expressed if they showed a fold-change value higher
than 1.5 and FDR lower than 0.05. Potential functional signiﬁcance
was assessed by Gene Ontology enrichment terms (Genomics Suite™)
(Partek). Genes differentially expressed by the CD133highCD71low
52 L. Jin et al. / Stem Cell Research 16 (2016) 40–53compared to the CD133+CD71− cells are listed in Supplementary
Table 1. Data were deposited to the repository system Gene Expression
Omnibus.4.11. Statistical analysis
All values were shown as mean ± standard deviation. Signiﬁcance
was determined by Student's two-tailed t-test and P b 0.05 was consid-
ered signiﬁcant.
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